nyxthracis (previously obiltoxaximab sfl)
sfl pharmaceuticals deutschland gmbh - nyxthracis - anthrax - imunitný séra a imunoglobulíny, - obiltoxaximab sfl is indicated in combination with appropriate antibacterial drugs in all age groups for treatment of inhalational anthrax due to bacillus anthracis (see section 5. obiltoxaximab sfl is indicated in all age groups for post-exposure prophylaxis of inhalational anthrax when alternative therapies are not appropriate or are not available (see section 5.
ytracis
cis bio international - yttrium (90y) chloride - radionuklidové zobrazovanie - diagnostické rádiofarmaká - používať len na rádioaktívne značenie nosičových molekúl, ktoré boli špecificky vyvinuté a povolené na rádioaktívne značenie týmto rádioaktúlidom. radiopharmaceutical precursor - not intended for direct application to patients.
fleas away dog shampoo
ciprolon 200 mg/100 ml
hikma farmaceutica (portugal) s.a., portugalsko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
ciprinol
krka, d.d., novo mesto, slovinsko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
ciprinol 250
krka, d.d., novo mesto, slovinsko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
ciprinol 500
krka, d.d., novo mesto, slovinsko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
medociprin 250 mg
medochemie ltd., cyprus - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
medociprin 500 mg
medochemie ltd., cyprus - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)
ciplox 250
cipla europe nv, belgicko - ciprofloxacín - 42 - chemotherapeutica (vratane tuberkulostatik)